Earnings History Data for RAPT Therapeutics, Inc. (RAPT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
RAPT Therapeutics, Inc.
RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193, a CCR4 antagonist for allergic inflammatory disease. RAPT Therapeutics Inc. is based in San Francisco, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | RAPT | RAPT Therapeutics, Inc. | 108.20 | -0.47 | -0.56 | -0.82 | RAPT Therapeutics GAAP EPS of -$0.47 beats by $0.11 [11/12/2024 9:08 AM] |
1.73 | -0.02 (-1.06%) |
1.76 | 0.01 (0.57%) |
1.30 - 27.35 | 1,860,265 | 1,260,000 | 413,438 | ||
|
||||||||||||||||||
| 08-08-2024 | PM | RAPT | Rapt Therapeutics | 92.00 | -0.71 | -0.74 | 0.00 | RAPT Therapeutics GAAP EPS of -$0.71 beats by $0.05 [8/8/2024 8:49 AM] |
2.32 | -0.09 (-3.73%) |
2.39 | -0.02 (-0.79%) |
2.19 - 27.35 | 216,009 | 280,000 | 841 | ||
| 07-03-2024 | PM | RAPT | Rapt Therapeutics | 299.00 | -0.80 | -0.85 | 0.00 | RAPT Therapeutics GAAP EPS of -$0.80 [3/7/2024 11:25 AM] |
9.24 | 0.10 (1.09%) |
9.16 | 0.02 (0.22%) |
6.86 - 30.82 | 932,853 | 1,680,000 | 5,213 | ||
| 13-11-2023 | PM | RAPT | Rapt Therapeutics | 394.00 | -0.82 | -0.75 | 0.00 | 12.10 | 0.37 (3.15%) |
0.0 | 0.0 (0.00%) |
10.47 - 31.45 | 363,400 | 540,000 | 0 | |||
|
|
||||||||||||||||||
| 11-05-2023 | PM | 8:00 AM ET (May 11) |
RAPT | RAPT Therapeutics, Inc. | 648.76 | -0.76 | -0.64 | -0.69 | RAPT Therapeutics GAAP EPS of -$0.76 misses by $0.08 [5/11/2023 9:44 AM] |
18.90 | -0.76 (-3.87%) |
19.30 | -0.36 (-1.83%) |
10.94 - 32.45 | 247,463 | 320,000 | 1,035 | |
| 14-03-2023 | PM | RAPT | Rapt Therapeutics | 739.00 | -0.64 | -0.67 | 0.00 | RAPT Therapeutics GAAP EPS of -$0.64 [3/14/2023 8:50 AM] |
19.64 | -6.96 (-26.17%) |
24.66 | -1.95 (-7.33%) |
9.85 - 32.45 | 2,674,143 | 510,000 | 5,250 | ||
| 10-11-2022 | PM | RAPT | RAPT Therapeutics, Inc. | 571.78 | -0.63 | -0.65 | -0.63 | RAPT Therapeutics GAAP EPS of -$0.63 beats by $0.04 [11/10/2022 9:12 AM] |
22.10 | 4.68 (26.87%) |
17.42 | 0.0 (0.00%) |
9.85 - 40.74 | 361,018 | 270,000 | 7,858 | ||
| 11-08-2022 | PM | RAPT | RAPT Therapeutics, Inc. | 637.11 | -0.62 | -0.75 | -0.63 | RAPT Therapeutics GAAP EPS of -$0.62 beats by $0.12, revenue of $0.89M beats by $0.58M [8/11/2022 9:01 AM] |
24.36 | 0.72 (3.05%) |
23.64 | 0.0 (0.00%) |
9.86 - 40.74 | 240,115 | 240,000 | 2,986 | ||
| 11-05-2022 | PM | RAPT | RAPT Therapeutics, Inc. | 349.47 | -0.69 | -0.66 | -0.66 | RAPT Therapeutics GAAP EPS of -$0.69 misses by $0.01, revenue of $0.64M beats by $0.33M [5/11/2022 8:14 AM] |
11.16 | 0.08 (0.72%) |
12.00 | 0.92 (8.30%) |
9.86 - 43.26 | 678,952 | 540,000 | 466 | ||
|
||||||||||||||||||
| 10-11-2021 | AH | RAPT | Rapt Therapeutics | 1,129 | -0.63 | -0.60 | 0.00 | RAPT Therapeutics EPS misses by $0.01, beats on revenue [11/10/2021 4:46 PM] |
37.56 | -0.49 (-1.30%) |
38.06 | 0.0 (0.00%) |
14.63 - 43.26 | 179,051 | 200,000 | 8,086 | ||
|
||||||||||||||||||
| 11-08-2021 | PM | 8:00 AM ET (Aug 11) |
RAPT | Rapt Theraptics | 821.00 | -0.63 | -0.62 | 0.00 | RAPT Therapeutics EPS beats by $0.05, beats on revenue [8/11/2021 8:36 AM] |
33.07 | 0.79 (2.45%) |
33.07 | 0.0 (0.00%) |
14.63 - 43.26 | 136,333 | 200,000 | 38,621 | |
| 11-05-2021 | PM | RAPT | Rapt Theraptics | 509.00 | -0.66 | -0.52 | 0.00 | RAPT Therapeutics EPS misses by $0.04, beats on revenue [5/11/2021 8:50 AM] |
18.50 | -1.41 (-7.08%) |
19.11 | -0.80 (-4.02%) |
14.09 - 41.86 | 178,876 | 100,000 | 143 | ||
| 11-03-2021 | PM | RAPT | Rapt Theraptics | 456.00 | -0.52 | -0.54 | 0.00 | RAPT Therapeutics EPS beats by $0.07, beats on revenue [3/11/2021 9:24 AM] |
22.49 | 2.59 (13.02%) |
19.90 | 0.0 (0.00%) |
10.52 - 41.86 | 350,296 | 169,910 | 755 | ||
|
||||||||||||||||||
| 13-08-2020 | PM | RAPT | RAPT Therapeutics, Inc. | 538.90 | -0.51 | -0.49 | 0.00 | RAPT Therapeutics EPS beats by $0.07, beats on revenue [8/13/2020 10:56 AM] |
23.60 | 0.80 (3.51%) |
22.59 | -0.21 (-0.92%) |
10.52 - 51.21 | 18,315 | 116,187 | 14,647 | ||
|
|
||||||||||||||||||